Garen Gotfredson

Array ( [id] => 20676544 [patent_doc_number] => 20260115353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-04-30 [patent_title] => HYDROLYZED COLLAGEN COMPOSITIONS WITH ANTIBIOTICS AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 19/371959 [patent_app_country] => US [patent_app_date] => 2025-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5083 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19371959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20510167 [patent_doc_number] => 20260034266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-02-05 [patent_title] => PARTICLE-FORM HYBRID-SCALE FIBER MATRIX [patent_app_type] => utility [patent_app_number] => 19/353408 [patent_app_country] => US [patent_app_date] => 2025-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3700 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19353408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20510165 [patent_doc_number] => 20260034264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-02-05 [patent_title] => PARTICLE-FORM HYBRID-SCALE FIBER MATRIX [patent_app_type] => utility [patent_app_number] => 19/353328 [patent_app_country] => US [patent_app_date] => 2025-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3700 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19353328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20510166 [patent_doc_number] => 20260034265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-02-05 [patent_title] => PARTICLE-FORM HYBRID-SCALE FIBER MATRIX [patent_app_type] => utility [patent_app_number] => 19/353396 [patent_app_country] => US [patent_app_date] => 2025-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3705 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19353396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20553951 [patent_doc_number] => 20260053731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-02-26 [patent_title] => MICRONEEDLE PARTICLES FOR ENHANCED TOPICAL TRANSDERMAL DRUG DELIVERY [patent_app_type] => utility [patent_app_number] => 19/260463 [patent_app_country] => US [patent_app_date] => 2025-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8315 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19260463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20092226 [patent_doc_number] => 20250222162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-10 [patent_title] => PARTICLE-FORM HYBRID-SCALE FIBER MATRIX [patent_app_type] => utility [patent_app_number] => 19/093009 [patent_app_country] => US [patent_app_date] => 2025-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3700 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19093009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19982779 [patent_doc_number] => 20250121001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-17 [patent_title] => METHOD FOR ENHANCING EMBRYO IMPLANTATION [patent_app_type] => utility [patent_app_number] => 18/911290 [patent_app_country] => US [patent_app_date] => 2024-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6315 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18911290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19798892 [patent_doc_number] => 20250064817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-27 [patent_title] => METHODS OF IMPROVING MYOCARDIAL PERFORMANCE IN FONTAN PATIENTS USING UDENAFIL COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 18/766315 [patent_app_country] => US [patent_app_date] => 2024-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25220 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18766315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19510655 [patent_doc_number] => 20240342341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-17 [patent_title] => Porous Foams Derived From Extracellular Matrix, Porous Foam ECM Medical Devices, and Methods of Use and Making Thereof [patent_app_type] => utility [patent_app_number] => 18/660108 [patent_app_country] => US [patent_app_date] => 2024-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4657 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18660108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19359324 [patent_doc_number] => 20240261358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => KAVA COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/639758 [patent_app_country] => US [patent_app_date] => 2024-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6649 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18639758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19316945 [patent_doc_number] => 20240238485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-18 [patent_title] => Local Drug Delivery Devices and Methods for Treating Cancer [patent_app_type] => utility [patent_app_number] => 18/621669 [patent_app_country] => US [patent_app_date] => 2024-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5944 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18621669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19298274 [patent_doc_number] => 20240226840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-11 [patent_title] => LAYERED PARTICLES AND PROCESSES THEREOF [patent_app_type] => utility [patent_app_number] => 18/617354 [patent_app_country] => US [patent_app_date] => 2024-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10563 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18617354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19462315 [patent_doc_number] => 20240315984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-26 [patent_title] => MICROSPHERE-BASED DRUG DELIVERY PLATFORM FOR DELIVERY OF IMMUNOTHERAPEUTIC AGENTS [patent_app_type] => utility [patent_app_number] => 18/612755 [patent_app_country] => US [patent_app_date] => 2024-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3975 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18612755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19830793 [patent_doc_number] => 20250082579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-13 [patent_title] => ORALLY DISINTEGRATING NICOTINE TABLET FOR USE UNDER LIP [patent_app_type] => utility [patent_app_number] => 18/608586 [patent_app_country] => US [patent_app_date] => 2024-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13079 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -53 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18608586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19279927 [patent_doc_number] => 20240216399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-04 [patent_title] => CANNABINOID COMPOSITION AND METHOD OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 18/603705 [patent_app_country] => US [patent_app_date] => 2024-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4033 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18603705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20471845 [patent_doc_number] => 20260014063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-01-15 [patent_title] => Antiperspirant and Deodorant Composition [patent_app_type] => utility [patent_app_number] => 18/998139 [patent_app_country] => US [patent_app_date] => 2024-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 194 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18998139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19246644 [patent_doc_number] => 20240197628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-20 [patent_title] => INHALABLE DRY POWDER FORMULATIONS COMPRISING ANGIOGENESIS INHIBITORS [patent_app_type] => utility [patent_app_number] => 18/589995 [patent_app_country] => US [patent_app_date] => 2024-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26258 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18589995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20191537 [patent_doc_number] => 20250268247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-28 [patent_title] => ESSENTIAL OIL COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/589367 [patent_app_country] => US [patent_app_date] => 2024-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3925 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18589367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19691107 [patent_doc_number] => 20250009652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-09 [patent_title] => COMPOSITIONS FOR RESPIRATORY DELIVERY OF ACTIVE AGENTS AND ASSOCIATED METHODS AND SYSTEMS [patent_app_type] => utility [patent_app_number] => 18/582344 [patent_app_country] => US [patent_app_date] => 2024-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30398 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18582344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19387888 [patent_doc_number] => 20240277758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-22 [patent_title] => USE OF SODIUM THIOSULFATE FOR THE TREATMENT OF SULFUR MUSTARD EXPOSURE [patent_app_type] => utility [patent_app_number] => 18/397569 [patent_app_country] => US [patent_app_date] => 2023-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19345 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18397569 [rel_patent_id] =>[rel_patent_doc_number] =>)